Gameto - About the company
Gameto is an acquired company based in New York City (United States), founded in 2020 by Dina Radenkovic. It operates as a Developer of therapeutics for the treatment of fertility and menopause. Gameto has raised $127M in funding from investors like Insight Partners, Two Sigma Ventures and RA Capital Management. The company has 45 active competitors, including 10 funded and 8 that have exited. Its top competitors include companies like Rejoni, Sprout Pharmaceuticals and Hope Medicine.
Company Details
Developer of therapeutics for the treatment of fertility and menopause. It offers Fertilo an investigational fertility therapy that uses engineered ovarian support cells derived from induced pluripotent stem cells. It also offers Deovo an in vitro organoid model of the female reproductive system to develop drugs for ovarian cancer.
- Website
- www.gametogen.com/
- Registered Address
- 1999 BRYAN ST STE 900,DALLAS,TX,75201,57
Key Metrics
Founded Year
2020
Location
New York City, United States
Stage
Acquired
Total Funding
$127M in 5 rounds
Latest Funding Round
Investors
Ranked
1st among 45 active competitors
Employee Count
58 as on Sep 30, 2026
Exit Details
Acquired by Ferring Pharmaceuticals (Oct 27, 2026)
Legal entities associated with Gameto
Gameto is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
Gameto, Inc. CIN: 32089373321 , United States, Active | Apr 10, 2023 | - | - | - |
Gameto's acquisition details
Gameto got acquired by Ferring Pharmaceuticals on Oct 27, 2026 at an acquisition amount of $*****.
Click here to take a look at Gameto's acquisition in detail
Sign up to download Gameto's company profile
Gameto's funding and investors
Gameto has raised a total funding of $127M over 5 rounds. Its first funding round was on Mar 2020. Its latest funding round was a Series C round on Jul 21, 2025 for $*****. 11 investors participated in its latest round. Gameto has 24 institutional investors and 8 angel investors.
Here is the list of recent funding rounds of Gameto:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jul 21, 2025 | 8961677 | Series C | 6944982 | 4035367 | 1175692 | 3497184 |
May 20, 2024 | 5461453 | Series B | 8229451 | 5368715 | 5634724 | |
Sep 14, 2022 | 6773357 | Series A | 9619180 | 2335418 |
View details of Gameto's funding rounds and investors
Gameto's founders and board of directors
Founder? Claim ProfileThe founders of Gameto is Dina Radenkovic. Dina Radenkovic is the CEO of Gameto.
Here are the details of Gameto's key team members:
- Dina Radenkovic: Co-Founder & CEO of Gameto. Contact Info: 1 email address
View details of Gameto's Founder profiles and Board Members
Gameto's employee count trend
Gameto has 58 employees as of Sep 26. Here is Gameto's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Gameto's Competitors and alternates
Top competitors of Gameto include Rejoni, Sprout Pharmaceuticals and Hope Medicine. Here is the list of Top 10 competitors of Gameto, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Gameto 2020, New York City (United States), Acquired | Developer of therapeutics for the treatment of fertility and menopause | $127M | 61/100 | |
2nd | Rejoni 2020, Bedford (United States), Series B | Developer of therapeutics to treat women health conditions | $66.3M | 61/100 | |
3rd | Sprout Pharmaceuticals 2011, Raleigh (United States), Acquired | Developer of drugs for hypoactive sexual desire disorder in women | $185M | 59/100 | |
4th | Hope Medicine 2018, Shanghai (China), Series B | Developer of monoclonal antibodies for the treatment of multiple diseases | $56M | 55/100 | |
5th | Manufacturer of women care medicines | $19M | 52/100 | ||
6th | Lighthouse Pharma 2019, San Francisco (United States), Series A | Developer of therapeutics for neurology and infectious diseases | $15.2M | 51/100 | |
7th | Cyclana Bio 2025, Cambridge (United Kingdom), Seed | Developer of tissue and matrix biology treatments for women's health | $6.71M | 49/100 | |
8th | FimmCyte 2022, Basel (Switzerland), Funding Raised | Developer of therapeutics to treat endometriosis | - | 45/100 | |
9th | ObsEva 2012, Geneva (Switzerland), Public | Developer of therapeutics for women's reproductive health and pregnancy | $94.7M | 44/100 | |
10th | Forendo Pharma 2013, Turku (Finland), Acquired | Provider of small molecule based therapeutics for reproductive health | $25.6M | 44/100 |
Looking for more details on Gameto's competitors? Click here to see the top ones
Gameto's Investments and acquisitions
Gameto has made no investments or acquisitions yet.
Reports related to Gameto
Here is the latest report on Gameto's sector:
News related to Gameto
Media has covered Gameto for a total of 2 events in the last 1 year, 1 of them has been about partnerships.
•
Ferring to acquire next-gen IVF startup Gameto for up to $1.4BBioPharmaDive•Oct 28, 2026•Ferring Pharmaceuticals, Swarmer, Gameto
•
Gameto Licenses Foundational Meiosis IP to Advance Human Ovary-in-aGlobeNewswire•Jan 29, 2026•Gameto
•
Gameto's $44M Series C to Redefine Reproductive Care, Recruits First Patients for Stem Cell Phase 3 Trialhttps://www.intelligence360.news/•Sep 01, 2025•Gameto, Overwater Ventures
•
Gameto Secures $44M Series C to Advance Reproductive Health TherapiesSilicon Valley Journals•Aug 13, 2025•Gameto, Overwater Ventures, PagsGroup, Arcadia and 8 others
•
Gameto Announces First U.S. Clinical Site Open for Enrollment in Fertilo StudyBusiness Wire•Apr 24, 2025•Gameto, https://rfcfamily.com
•
•
Gameto Announces FDA IND Clearance for Fertilo, the First iPSC-Based Therapy to Enter U.S. Phase 3 Clinical TrialsBusiness Wire•Jan 30, 2025•Gameto
•
Fertility startup to begin Phase 3 study of stem cell therapy for IVFEndPoints News•Jan 30, 2025•Gameto
•
Gameto Announces World’s First Live Birth Using Fertilo Procedure that Matures Eggs Outside the BodyBusiness Wire•Dec 16, 2024•Gameto
•
Gameto Partners with Australian-Based IVF Clinic IVFAustralia of Virtus HealthBusiness Wire•Dec 12, 2024•Gameto, Virtus Health
Are you a Founder ?
FAQs about Gameto
Explore our recently published companies
- Mon Bottier - Nantes based, 2010 founded, Unfunded company
- Sanigrif - Getafe based, 1969 founded, Acquired company
- Kurta Palace - Delhi based, 2012 founded, Unfunded company
- Beauty Success Group - Saint Astier based, 1995 founded, Series A company
- Bonprix - Tver based, 1986 founded, Unfunded company
- Ninematernitywear - Mumbai based, 2012 founded, Deadpooled company
